Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
7.16
+0.22 (3.17%)
At close: Jul 22, 2025, 4:00 PM
7.07
-0.09 (-1.26%)
After-hours: Jul 22, 2025, 4:45 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Commercial Products | 497.30M | Log In | Log In | Log In | Log In | Upgrade |
Medical Countermeasures Products | 447.20M | Log In | Log In | Log In | Log In | Upgrade |
Services | 78.50M | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items | 26.30M | Log In | Log In | Log In | Log In | Upgrade |
Reconciling Items Growth | -36.47% | Log In | Log In | Log In | Log In | Upgrade |
Government - Medical Countermeasures and Commercial Product | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing Services | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing Services Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Nasal Naloxone Products | - | Log In | Log In | Log In | Log In | Upgrade |
Nasal Naloxone Products Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing - Services | - | Log In | Log In | Log In | Log In | Upgrade |
Contract Development and Manufacturing - Leases | - | Log In | Log In | Log In | Log In | Upgrade |
Anthrax Vaccines | - | Log In | Log In | Log In | Log In | Upgrade |
Anthrax Vaccines Growth | - | Log In | Log In | Log In | Log In | Upgrade |
ACAM2000 | - | Log In | Log In | Log In | Log In | Upgrade |
ACAM2000 Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Other | 217.90M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 163.16% | Log In | Log In | Log In | Log In | Upgrade |
United States | 607.20M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | -31.74% | Log In | Log In | Log In | Log In | Upgrade |
Canada | 224.20M | Log In | Log In | Log In | Log In | Upgrade |
Canada Growth | 50.87% | Log In | Log In | Log In | Log In | Upgrade |
Other | 217.90M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 163.16% | Log In | Log In | Log In | Log In | Upgrade |